DSP Healthcare Fund - Growth - Regular Plan

Other Plans and Options
  • (-1.41%)Nav, as on 20-09-2021

  • Previous Nav

  • Net Change on 20-09-2021

  • PersonalFN Rating

  • Assets (Cr.)

  • Expense Ratio

Fund Overview Growth | Regular Plan

  • Fund House

  • Launch Date

  • Benchmark

  • Minimum Investment (₹)

  • Minimum Addl Investment (₹)

  • Exit Load (%)

  • Minimum SIP Investment (₹)

  • Minimum STP Investment (₹)

  • Minimum SWP Investment (₹)

  • 52 Week Low Nav (₹)

  • 52 Week Low Nav Date

  • 52 Week High Nav (₹)

  • 52 Week High Nav Date

Fund Objective

The primary investment objective of the scheme is to seek to generate consistent returns bypredominantly investing in equity and equity related securities of pharmaceutical and healthcarecompanies.

Fund Performance

Scheme Name 1-Month Return (%) 3-Month Return (%) 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Since Inception
NIFTY 50 - TRI N/A N/A N/A N/A N/A N/A
S&P BSE Health Care 1.64 5.39 27.91 18.05 9.57 15.49
S&P BSE Health Care - TRI 1.71 5.72 28.65 18.85 10.28 15.73

Returns upto 1 year is Absolute, and above 1 year are Compounded Annualised

Peer Fund Comparison

Scheme Name Launch Date Ratings 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Expense Ratio (%) Assets (Cr.)
Nippon India Pharma Fund-Growth Plan-Growth Jun 05, 2004 32.22 23.65 16.10 1.95 5,667.10
SBI HEALTHCARE OPPORTUNITIES FUND - REGULAR PLAN -GROWTH Jul 14, 1999 27.68 20.73 9.50 2.08 2,048.27
UTI Healthcare Fund - Regular Plan - Growth Option Aug 01, 2005 27.36 21.82 12.04 2.36 897.05
Tata India Pharma & Healthcare Fund-Regular Plan-Growth Dec 28, 2015 27.42 22.76 12.77 2.69 609.91

Fund Holdings as on 31-August-2021

  • Sun Pharmaceutical Industries Limited

  • Max Healthcare Institute Limited

  • Cipla Limited

  • Apollo Hospitals Enterprise Limited

  • IPCA Laboratories Limited

  • Divi's Laboratories Limited

  • Procter & Gamble Health Limited

  • Lupin Limited

  • Dr. Reddy's Laboratories Limited

  • Alkem Laboratories Limited

  • Indoco Remedies Limited

  • Dr. Lal Path Labs Ltd.

  • Intuitive Surgical Inc

  • Torrent Pharmaceuticals Limited

  • Globus Medical Inc

  • ICICI Lombard General Insurance Company Limited

  • Narayana Hrudayalaya Ltd.

  • Abiomed Inc

  • Syngene International Limited

  • Abbott Laboratories

  • JB Chemicals & Pharmaceuticals Limited

  • Net Receivables/Payables

  • Alembic Pharmaceuticals Limited

  • Unichem Laboratories Limited

  • Aarti Drugs Limited

  • Kovai Medical Center & Hospital Limited

  • TREPS / Reverse Repo Investments / Corporate Debt Repo

View More

  • Pharmaceuticals & Drugs

  • Hospital & Healthcare Services

  • Miscellaneous

  • Insurance

View More

Fund Manager

  • Education:B.Com, FCA
  • Experience:14 years
  • Basic Details:Mr.Vinit Sambre has 14 Years of Experience in Mutual Fund Industry. He joined DSPBRIM in July 2007, as Portfolio Analyst for the firm's PMS division. Previously, he was with DSP Merrill Lynch as a part of its Global Private Client business. He spent 20 months at DSP Merrill Lynch as Equity Strategist. Prior to DSP Merrill Lynch, he was employed with IL&FS Investsmart Limited as an Equity Analyst in their PMS division. Prior to that, he has worked with UTI Investment Advisory Services as Equity Analyst for the offshore fund - India Growth Fund. Vinit is a Chartered Accountant from Institute of Chartered Accountant of India (Nov'1997).
  • Funds Managed:
  • DSP Focus Fund
  • DSP Healthcare Fund
  • DSP Midcap Fund
  • DSP Small Cap Fund
  • DSP Top 100 Equity Fund
  • DSP Focus Fund
  • DSP Healthcare Fund
  • DSP Midcap Fund
  • DSP Small Cap Fund
  • DSP Top 100 Equity Fund

  • Cash

  • Equity

View More

About DSP Healthcare Fund

Scheme Analysis

DSP Healthcare Fund is a Equity - Sectoral Fund - Pharma & Health Care fund and belongs to DSP Mutual Fund. It was launched on 30-Nov-2018 and currently has an AUM of ₹1,537.71 crore. DSP Healthcare Fund is benchmarked against NIFTY 50 - TRI as primary index and S&P BSE Health Care as primary index and S&P BSE Health Care - TRI as secondary index.

The NAV of DSP Healthcare Fund ended down ₹-0.34(-1.41%)yesterday to ₹23.441.

Among its top 3 holdings the fund has exposure to Sun Pharmaceutical Industries Limited, and

The DSP Healthcare Fund is managed by Vinit Sambre and Jay Kothari.

Fund House Contact

Mafatlal Centre, 10th Floor, Nariman Point, Mumbai - 400 021

+91 (22) 66578000
+91 (22) 66578181